Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
03:31pm, Tuesday, 07'th Oct 2025
Amgen is the latest drugmaker to sell certain drugs directly to consumers amid pressure from President Donald Trump. Meanwhile, Dr. Oz talks GLP-1s for obesity.
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%
02:46pm, Tuesday, 07'th Oct 2025
AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
06:51pm, Monday, 06'th Oct 2025
Amgen (AMGN) reached $294.12 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts
11:09am, Monday, 06'th Oct 2025
The biotechnology company said that it has launched AmgenNow, a new direct-to-patient program, starting with its drug Repatha.
Here's Why Amgen (AMGN) is a Strong Value Stock
10:40am, Monday, 06'th Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Amgen to sell cholesterol drug at 60% discount direct to US consumers
09:03am, Monday, 06'th Oct 2025
Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol medication Repatha at a discounted cash price, becoming the latest pharmaceutical company responding to U.S. political pressur
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
09:00am, Monday, 06'th Oct 2025
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif. , Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a ne
October Dogs Of The Dow Flash One Ideal 'Safer' Dividend Buy
12:18pm, Saturday, 04'th Oct 2025
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price. Analyst forecasts suggest top-ten Dow Dogs could deliver average net
4 Reasons to Buy Amgen Stock Right Now
06:45am, Saturday, 04'th Oct 2025
Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (AMGN 0.19%) started the year strong, bu
Cramer's Stop Trading: Amgen
10:22am, Friday, 03'rd Oct 2025
Jim Cramer breaks down why he's keeping an eye on shares of Amgen.
The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks
03:15pm, Thursday, 02'nd Oct 2025
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
10:51am, Thursday, 02'nd Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
09:00am, Thursday, 02'nd Oct 2025
Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy Alone Repatha is Now the First and Only PCSK
2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
03:26am, Thursday, 02'nd Oct 2025
There are a million and one ways to put your money to work on Wall Street. It might surprise you to learn that investing in dividend growth stocks isn't just one of the easiest; it's also one of the m
